Insmed (INSM) Capital Leases (2010 - 2026)

Insmed has reported Capital Leases for 12 years, with the latest figure at $18.9 million in Q2 2026.

• On a quarterly basis, Capital Leases fell 15.82% year-over-year to $18.9 million in Q2 2026; TTM through Jun 2026 was $18.9 million, a 15.82% decrease from a year earlier, with the FY2025 full-year figure at $20.7 million, down 13.9% from the prior year.
• Capital Leases was $18.9 million for Q2 2026 at Insmed, down from $19.8 million in the prior quarter.
• The five-year high for Capital Leases was $29.6 million in Q4 2022, with the low at $18.9 million in Q2 2026.
• Average Capital Leases over 5 years is $24.4 million, with a median of $23.8 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Capital Leases jumped 110.14% in 2022, then slipped 15.82% in 2026.
• Over 5 years, Capital Leases stood at $29.6 million in 2022, then declined by 8.81% to $27.0 million in 2023, then decreased by 10.96% to $24.1 million in 2024, then declined by 13.9% to $20.7 million in 2025, then retreated by 8.83% to $18.9 million in 2026.
• The last three Capital Leases figures came in at $18.9 million (Q2 2026), $19.8 million (Q1 2026), and $20.7 million (Q4 2025), per Business Quant data.